Inovio Pharmaceuticals(CH:GBM)
CH:GBM
Inovio Pharmaceuticals earnings date
Inovio Pharmaceuticals (GBM) Q2 2023 Earnings Report
1 Followers
CH:GBM Q2 2023 EPS Results
- Actual EPS
- -CHF 1.32
- Consensus EPS
- -CHF 1.47
- Beat/Miss
- Beat by +CHF 0.15
- One Year Ago EPS
- -CHF 4.65
CH:GBM Q2 2023 Revenue Results
- Actual Revenue
- CHF 190.54K
- Expected Revenue
- CHF 231.88K
- Beat/Miss
- Missed by -CHF 41.34K
- YoY Revenue Growth
- -71.19%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/09/2023
- Time
- After Close
- Conference Call
- Wednesday, August 9, 2023
CH:GBM Upcoming Earnings
Inovio Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
CH:GBM Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:GBM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.11- | 0.05 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.17-0.42 | -0.73 | 42.53% (+0.31) | |
| Aug 12, 2026 | 2026 (Q2) | -0.18-0.06 | -0.51 | 88.52% (+0.46) | |
| May 13, 2026 | 2026 (Q1) | -0.30-0.24 | -0.43 | 45.10% (+0.19) | |
| Mar 12, 2026 | 2025 (Q4) | -0.300.05 | -0.55 | 109.23% (+0.60) | |
| Nov 10, 2025 | 2025 (Q3) | -0.36-0.73 | -0.75 | 2.25% (+0.02) | |
| Aug 12, 2025 | 2025 (Q2) | -0.51-0.51 | -1 | 48.74% (+0.49) | |
| May 13, 2025 | 2025 (Q1) | -0.58-0.43 | -1.1 | 61.07% (+0.67) | |
| Mar 18, 2025 | 2024 (Q4) | -0.71-0.55 | -0.93 | 40.91% (+0.38) | |
| Nov 14, 2024 | 2024 (Q3) | -0.97-0.75 | -1.32 | 42.95% (+0.56) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

